Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 4
2006 2
2007 3
2008 5
2009 8
2010 4
2011 8
2012 6
2013 8
2014 12
2015 14
2016 8
2017 9
2018 18
2019 30
2020 26
2021 36
2022 51
2023 46
2024 20

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Results by year

Filters applied: . Clear all
Page 1
The cancer metabolic reprogramming and immune response.
Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, Liang J, Tang Y, Su M, Luo X, Yang Y, Shi Y, Wang H, Zhou Y, Liao Q. Xia L, et al. Among authors: luo x. Mol Cancer. 2021 Feb 5;20(1):28. doi: 10.1186/s12943-021-01316-8. Mol Cancer. 2021. PMID: 33546704 Free PMC article. Review.
TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.
Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P. Migone TS, et al. Among authors: luo x. Immunity. 2002 Mar;16(3):479-92. doi: 10.1016/s1074-7613(02)00283-2. Immunity. 2002. PMID: 11911831 Free article.
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity.
Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, Yi P, Pan Q, Rao S, Han Y, Tang Y, Su M, Luo X, Yang Y, Chen X, Yang L, Zhou Y, Liao Q. Lin J, et al. Among authors: luo x. Oncogene. 2022 Feb;41(7):1024-1039. doi: 10.1038/s41388-021-02148-y. Epub 2022 Jan 8. Oncogene. 2022. PMID: 34997215 Free PMC article.
Organoids: opportunities and challenges of cancer therapy.
Jiang X, Oyang L, Peng Q, Liu Q, Xu X, Wu N, Tan S, Yang W, Han Y, Lin J, Xia L, Peng M, Tang Y, Luo X, Su M, Shi Y, Zhou Y, Liao Q. Jiang X, et al. Among authors: luo x. Front Cell Dev Biol. 2023 Jul 27;11:1232528. doi: 10.3389/fcell.2023.1232528. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37576596 Free PMC article. Review.
The function of prohibitins in mitochondria and the clinical potentials.
Oyang L, Li J, Jiang X, Lin J, Xia L, Yang L, Tan S, Wu N, Han Y, Yang Y, Luo X, Li J, Liao Q, Shi Y, Zhou Y. Oyang L, et al. Among authors: luo x. Cancer Cell Int. 2022 Nov 8;22(1):343. doi: 10.1186/s12935-022-02765-x. Cancer Cell Int. 2022. PMID: 36348375 Free PMC article. Review.
Rac1, A Potential Target for Tumor Therapy.
Liang J, Oyang L, Rao S, Han Y, Luo X, Yi P, Lin J, Xia L, Hu J, Tan S, Tang L, Pan Q, Tang Y, Zhou Y, Liao Q. Liang J, et al. Among authors: luo x. Front Oncol. 2021 May 17;11:674426. doi: 10.3389/fonc.2021.674426. eCollection 2021. Front Oncol. 2021. PMID: 34079763 Free PMC article. Review.
285 results